John Glenn

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Orlando, FL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John Glenn
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John Glenn

Form 4 holding CFO

IRADIMED CORP

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$2,194,711
Report date
20 Jun 2026
Price
$54.18
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CFO

IRADIMED CORP

Security class
Performance-based Restricted Stock Units
Shares / value
0
Estimated value
$1,252,580
Report date
07 Dec 2025
Price
$54.18
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

EKSO BIONICS HOLDINGS, INC.

Security class
Common Stock
Shares / value
35,130
Estimated value
$34,975
Report date
22 Mar 2022
Price
$0.9956
Ownership
Direct

Insider Reports Filed by John Glenn

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .